33.70
price up icon0.99%   0.33
pre-market  Pre-mercato:  33.70  
loading
Precedente Chiudi:
$33.37
Aprire:
$34
Volume 24 ore:
976.03K
Relative Volume:
1.29
Capitalizzazione di mercato:
$2.13B
Reddito:
-
Utile/perdita netta:
$-107.85M
Rapporto P/E:
-15.25
EPS:
-2.21
Flusso di cassa netto:
$-106.82M
1 W Prestazione:
-2.57%
1M Prestazione:
-20.89%
6M Prestazione:
-2.74%
1 anno Prestazione:
+125.72%
Intervallo 1D:
Value
$33.34
$34.35
Intervallo di 1 settimana:
Value
$32.25
$36.28
Portata 52W:
Value
$15.37
$51.61

Vera Therapeutics Inc Stock (VERA) Company Profile

Name
Nome
Vera Therapeutics Inc
Name
Telefono
650-770-0077
Name
Indirizzo
2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE
Name
Dipendente
82
Name
Cinguettio
Name
Prossima data di guadagno
2024-08-08
Name
Ultimi documenti SEC
Name
VERA's Discussions on Twitter

Confronta VERA con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
VERA
Vera Therapeutics Inc
33.70 2.13B 0 -107.85M -106.82M -2.21
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
427.89 110.19B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
687.80 75.58B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
647.39 38.71B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
264.99 34.18B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
117.25 28.11B 3.30B -501.07M 1.03B -2.1146

Vera Therapeutics Inc Stock (VERA) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-11-21 Iniziato Wells Fargo Overweight
2024-10-16 Iniziato Scotiabank Sector Outperform
2024-01-25 Iniziato Oppenheimer Outperform
2024-01-08 Iniziato Cantor Fitzgerald Overweight
2023-12-18 Iniziato Raymond James Outperform
2023-11-10 Aggiornamento Jefferies Hold → Buy
2023-08-16 Iniziato Guggenheim Buy
2023-01-04 Downgrade Jefferies Buy → Hold
2023-01-04 Downgrade Wedbush Outperform → Neutral
2022-07-12 Iniziato JP Morgan Overweight
2022-05-02 Iniziato H.C. Wainwright Buy
2022-04-19 Iniziato Wedbush Outperform
Mostra tutto

Vera Therapeutics Inc Borsa (VERA) Ultime notizie

pulisher
Jan 21, 2025

Vera Therapeutics, Inc. (NASDAQ:VERA) Receives Average Rating of “Buy” from Analysts - Defense World

Jan 21, 2025
pulisher
Jan 20, 2025

Possible Bearish Signals With Vera Therapeutics Insiders Disposing Stock - Simply Wall St

Jan 20, 2025
pulisher
Jan 20, 2025

Vera Therapeutics Releases Updated Corporate Presentation Following J.P. Morgan Healthcare Conference - Defense World

Jan 20, 2025
pulisher
Jan 18, 2025

When the Price of (VERA) Talks, People Listen - Stock Traders Daily

Jan 18, 2025
pulisher
Jan 17, 2025

JPMorgan Chase & Co. Decreases Holdings in Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World

Jan 17, 2025
pulisher
Jan 15, 2025

Nephrotic Syndrome Market Set to Grow Substantially Through 2034, DelveInsight Projects | GlaxoSmithKline, Goldfinch Bio, Inc., Travere Therapeutics, Inc., Aurinia Pharmaceuticals, Bristol-Myers Squib - The Globe and Mail

Jan 15, 2025
pulisher
Jan 15, 2025

Vera Therapeutics Getting Closer To Key Technical Benchmark - MSN

Jan 15, 2025
pulisher
Jan 15, 2025

Head to Head Comparison: CannTrust (OTCMKTS:CNTTF) versus Vera Therapeutics (NASDAQ:VERA) - Defense World

Jan 15, 2025
pulisher
Jan 14, 2025

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Jan 14, 2025
pulisher
Jan 14, 2025

Vera Therapeutics Awards New Employee Stock Options and RSUs Worth $42.19 Per Share - StockTitan

Jan 14, 2025
pulisher
Jan 14, 2025

Vera Therapeutics Stocks Surge Amid Strategic Moves - TipRanks

Jan 14, 2025
pulisher
Jan 14, 2025

Vera Therapeutics (NASDAQ:VERA) Shares Gap Down Following Insider Selling - Defense World

Jan 14, 2025
pulisher
Jan 13, 2025

What's Going On With Vera Therapeutics Stock?Vera Therapeutics (NASDAQ:VERA) - Benzinga

Jan 13, 2025
pulisher
Jan 13, 2025

Vera Therapeutics (NASDAQ:VERA) Shares Gap Down After Insider Selling - MarketBeat

Jan 13, 2025
pulisher
Jan 13, 2025

Vera Therapeutics Highlights Atacicept Progress at Conference - TipRanks

Jan 13, 2025
pulisher
Jan 13, 2025

Vera Therapeutics Acquires Global Rights to Novel, Next Generation Dual BAFF/APRIL Inhibitor - GlobeNewswire

Jan 13, 2025
pulisher
Jan 13, 2025

Vera Therapeutics Secures Stanford's Novel B Cell Therapy VT-109 in Exclusive Deal - StockTitan

Jan 13, 2025
pulisher
Jan 11, 2025

Vera Therapeutics CEO Marshall sells shares for $730,535 By Investing.com - Investing.com Australia

Jan 11, 2025
pulisher
Jan 10, 2025

Vera Therapeutics, Inc. (NASDAQ:VERA) CEO Marshall Fordyce Sells 17,500 Shares - MarketBeat

Jan 10, 2025
pulisher
Jan 10, 2025

Vera Therapeutics (NASDAQ:VERA) Trading Down 7.3%Should You Sell? - MarketBeat

Jan 10, 2025
pulisher
Jan 08, 2025

Vera Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times

Jan 08, 2025
pulisher
Jan 07, 2025

How to Take Advantage of moves in (VERA) - Stock Traders Daily

Jan 07, 2025
pulisher
Jan 07, 2025

Is Vera Therapeutics The NEXT BIG THING? Stock Price Soars! - Truth or Fiction

Jan 07, 2025
pulisher
Jan 07, 2025

Vera Therapeutics to Present at J.P. Morgan Healthcare Conference 2025 - StockTitan

Jan 07, 2025
pulisher
Jan 01, 2025

Franklin Resources Inc. Sells 5,859 Shares of Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World

Jan 01, 2025
pulisher
Dec 31, 2024

Certain Options of Vera Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 30-DEC-2024. - Marketscreener.com

Dec 31, 2024
pulisher
Dec 27, 2024

Vera Therapeutics, Inc. (NASDAQ:VERA) Given Average Rating of "Buy" by Brokerages - MarketBeat

Dec 27, 2024
pulisher
Dec 24, 2024

Geode Capital Management LLC Buys 20,223 Shares of Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World

Dec 24, 2024
pulisher
Dec 24, 2024

Vera Therapeutics, Inc. (NASDAQ:VERA) Position Boosted by Geode Capital Management LLC - MarketBeat

Dec 24, 2024
pulisher
Dec 23, 2024

Barclays PLC Acquires 41,394 Shares of Vera Therapeutics, Inc. (NASDAQ:VERA) - MarketBeat

Dec 23, 2024
pulisher
Dec 22, 2024

Vera Therapeutics: Strong Data In IgAN, But We May Be Too Late (NASDAQ:VERA) - Seeking Alpha

Dec 22, 2024
pulisher
Dec 20, 2024

Vera Therapeutics, Inc. (NASDAQ:VERA) CEO Sells $753,725.00 in Stock - MarketBeat

Dec 20, 2024
pulisher
Dec 20, 2024

Vera Therapeutics Insider Sold Shares Worth $753,680, According to a Recent SEC Filing - Marketscreener.com

Dec 20, 2024
pulisher
Dec 20, 2024

Wellington Management Group LLP Sells 92,568 Shares of Vera Therapeutics, Inc. (NASDAQ:VERA) - MarketBeat

Dec 20, 2024
pulisher
Dec 17, 2024

Vera Therapeutics, Inc. (NASDAQ:VERA) Shares Sold by State Street Corp - MarketBeat

Dec 17, 2024
pulisher
Dec 16, 2024

Lord Abbett & CO. LLC Increases Position in Vera Therapeutics, Inc. (NASDAQ:VERA) - MarketBeat

Dec 16, 2024
pulisher
Dec 15, 2024

Vera Therapeutics, Inc. (NASDAQ:VERA) Shares Purchased by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World

Dec 15, 2024
pulisher
Dec 14, 2024

Certain Class A common stock of Vera Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 15-DEC-2024. - Marketscreener.com

Dec 14, 2024
pulisher
Dec 14, 2024

Marshall Fordyce Sells 17,500 Shares of Vera Therapeutics, Inc. (NASDAQ:VERA) Stock - MarketBeat

Dec 14, 2024
pulisher
Dec 13, 2024

Vera Therapeutics CEO sells shares worth over $821k By Investing.com - Investing.com Canada

Dec 13, 2024
pulisher
Dec 13, 2024

Vera Therapeutics CEO sells shares worth over $821k - Investing.com

Dec 13, 2024
pulisher
Dec 12, 2024

Vera Therapeutics, Inc. (NASDAQ:VERA) Shares Purchased by Y Intercept Hong Kong Ltd - MarketBeat

Dec 12, 2024
pulisher
Dec 11, 2024

VERAVera Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan

Dec 11, 2024
pulisher
Dec 09, 2024

Vera Therapeutics Grants $8.5M in Stock Options, RSUs to Attract Key Talent - StockTitan

Dec 09, 2024
pulisher
Dec 08, 2024

Pier Capital LLC Invests $4.57 Million in Vera Therapeutics, Inc. (NASDAQ:VERA) - MarketBeat

Dec 08, 2024
pulisher
Dec 08, 2024

Vera Therapeutics, Inc. (NASDAQ:VERA) Shares Purchased by Point72 Asset Management L.P. - MarketBeat

Dec 08, 2024
pulisher
Dec 08, 2024

Vera Therapeutics, Inc. (NASDAQ:VERA) Shares Bought by Charles Schwab Investment Management Inc. - MarketBeat

Dec 08, 2024

Vera Therapeutics Inc Azioni (VERA) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$21.80
price up icon 4.81%
$73.47
price up icon 2.14%
$22.10
price up icon 16.13%
$367.97
price up icon 2.52%
biotechnology ONC
$218.70
price up icon 4.10%
$117.25
price up icon 4.75%
Capitalizzazione:     |  Volume (24 ore):